BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1634 related articles for article (PubMed ID: 24976336)

  • 1. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.
    Domingues R; de Carvalho GC; Aoki V; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 Jun; 14(1):171. PubMed ID: 27286889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
    Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
    Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
    Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
    Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns.
    Cardoso EC; Pereira NZ; Mitsunari GE; Oliveira LM; Ruocco RM; Francisco RP; Zugaib M; da Silva Duarte AJ; Sato MN
    PLoS One; 2013; 8(6):e67036. PubMed ID: 23826189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lichen planus: altered AIM2 and NLRP1 expression in skin lesions and defective activation in peripheral blood mononuclear cells.
    Domingues R; Pietrobon AJ; Carvalho GC; Pereira NZ; Pereira NV; Sotto MN; Aoki V; Duarte AJS; Sato MN
    Clin Exp Dermatol; 2019 Jun; 44(4):e89-e95. PubMed ID: 30552699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
    Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
    Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR activation pathways in HIV-1-exposed seronegative individuals.
    Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
    J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity.
    Kurt-Jones EA; Sandor F; Ortiz Y; Bowen GN; Counter SL; Wang TC; Finberg RW
    J Endotoxin Res; 2004; 10(6):419-24. PubMed ID: 15588425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
    Thomas A; Laxton C; Rodman J; Myangar N; Horscroft N; Parkinson T
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2969-78. PubMed ID: 17548497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.
    Lebre MC; van der Aar AM; van Baarsen L; van Capel TM; Schuitemaker JH; Kapsenberg ML; de Jong EC
    J Invest Dermatol; 2007 Feb; 127(2):331-41. PubMed ID: 17068485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells.
    Booth JS; Buza JJ; Potter A; Babiuk LA; Mutwiri GK
    Dev Comp Immunol; 2010 May; 34(5):572-8. PubMed ID: 20051250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
    Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
    J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual cycle influences Toll-like receptor responses.
    Dennison U; McKernan DP; Scully P; Clarke G; Cryan J; Dinan T
    Neuroimmunomodulation; 2012; 19(3):171-9. PubMed ID: 22262081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
    Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
    Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
    McDonald DR; Brown D; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.
    Forsbach A; Samulowitz U; Völp K; Hofmann HP; Noll B; Tluk S; Schmitz C; Wader T; Müller C; Podszuweit A; Lohner A; Curdt R; Uhlmann E; Vollmer J
    Nucleic Acid Ther; 2011 Dec; 21(6):423-36. PubMed ID: 22196370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.